US Stock MarketDetailed Quotes

XFOWW X4 PHARMACEUTICALS INC C/WTS 29/11/2024(TO PUR COM) CL B

Watchlist
  • 0.012
  • 0.0000.00%
15min DelayClose Aug 13 16:00 ET
0Market Cap0.00P/E (TTM)

X4 PHARMACEUTICALS INC C/WTS 29/11/2024(TO PUR COM) CL B Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Total revenue
560K
563K
0
0
0
0
0
0
0
0
Operating revenue
--560K
--563K
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
227K
268K
0
0
Gross profit
333K
295K
0
0
Operating expense
28.00%34.83M
32.50%34.19M
27.25%37.29M
22.08%107.52M
-1.48%25.2M
35.03%27.21M
25.45%25.81M
34.56%29.3M
16.89%88.08M
32.54%25.58M
Selling and administrative expenses
92.55%15.66M
30.13%13.28M
140.78%17.44M
31.40%35.51M
51.26%9.93M
34.56%8.13M
51.19%10.2M
-5.52%7.24M
9.38%27.02M
-8.02%6.56M
Research and development costs
0.48%19.17M
34.06%20.91M
-10.01%19.85M
17.95%72.02M
-19.68%15.27M
35.23%19.08M
12.88%15.6M
56.33%22.06M
20.56%61.06M
56.34%19.01M
Operating profit
-26.77%-34.5M
-31.36%-33.9M
-27.25%-37.29M
-22.08%-107.52M
1.48%-25.2M
-35.03%-27.21M
-25.45%-25.81M
-34.56%-29.3M
-16.89%-88.08M
-32.54%-25.58M
Net non-operating interest income expense
-120.73%-543K
-161.11%-611K
-194.89%-808K
68.34%-1.2M
53.38%-441K
75.50%-246K
74.40%-234K
69.89%-274K
-3.91%-3.77M
-2.60%-946K
Non-operating interest income
34.80%1.87M
71.23%1.57M
27.66%1.07M
1,992.24%4.58M
629.80%1.45M
9,814.29%1.39M
22,750.00%914K
27,733.33%835K
2,090.00%219K
6,500.00%198K
Non-operating interest expense
47.74%2.41M
89.55%2.18M
68.98%1.87M
44.68%5.78M
64.86%1.89M
60.51%1.63M
25.05%1.15M
21.47%1.11M
9.64%3.99M
23.68%1.14M
Other net income (expense)
-106.50%-1.64M
522.68%125.36M
-345.42%-13.65M
483.90%7.63M
354.89%6.54M
5,809.98%25.18M
-10,845.65%-29.66M
646.58%5.56M
79.51%-1.99M
74.29%-2.57M
Gain on sale of security
-107.41%-1.86M
167.70%20.22M
-352.90%-13.76M
315.87%7.07M
432.02%6.33M
--25.16M
-9,013.43%-29.86M
2,990.34%5.44M
564.75%1.7M
460.61%1.19M
Special income (charges)
--0
--105M
----
--0
--0
--0
--0
----
105.22%509K
--0
-Less:Impairment of capital assets
----
----
----
--0
----
----
----
----
--0
----
-Gain on sale of property,plant,equipment
--0
--105M
----
--0
--0
--0
--0
----
--509K
--0
Other non- operating income (expenses)
1,229.41%226K
-28.71%144K
-14.63%105K
113.20%554K
105.64%212K
103.85%17K
442.37%202K
105.00%123K
-1,085.21%-4.2M
-3,747.57%-3.76M
Income before tax
-1,509.52%-36.68M
263.12%90.85M
-115.47%-51.75M
-7.73%-101.09M
34.35%-19.1M
89.45%-2.28M
-162.62%-55.7M
-9.45%-24.02M
-5.82%-93.84M
3.69%-29.09M
Income tax
-42.31%15K
20.00%18K
375.00%19K
178.57%78K
135.71%33K
300.00%26K
275.00%15K
-82.61%4K
64.71%28K
366.67%14K
Net income
-1,492.02%-36.7M
263.04%90.83M
-115.51%-51.77M
-7.78%-101.17M
34.27%-19.13M
89.32%-2.31M
-162.64%-55.71M
-9.36%-24.02M
-5.83%-93.87M
3.65%-29.1M
Net income continuous Operations
-1,492.02%-36.7M
263.04%90.83M
-115.51%-51.77M
-7.78%-101.17M
34.27%-19.13M
89.32%-2.31M
-162.64%-55.71M
-9.36%-24.02M
-5.83%-93.87M
3.65%-29.1M
Minority interest income
Net income attributable to the parent company
-1,492.02%-36.7M
263.04%90.83M
-115.51%-51.77M
-7.78%-101.17M
34.27%-19.13M
89.32%-2.31M
-162.64%-55.71M
-9.36%-24.02M
-5.83%-93.87M
3.65%-29.1M
Preferred stock dividends
Other preferred stock dividends
0
-81.74%2.55M
0
Net income attributable to common stockholders
-1,492.02%-36.7M
263.04%90.83M
-115.51%-51.77M
-4.93%-101.17M
34.27%-19.13M
89.46%-2.31M
-162.64%-55.71M
0.84%-24.02M
6.07%-96.41M
18.96%-29.1M
Basic earnings per share
Diluted earnings per share
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Total revenue 560K563K00000000
Operating revenue --560K--563K--0--0--0--0--0--0--0--0
Cost of revenue 227K268K00
Gross profit 333K295K00
Operating expense 28.00%34.83M32.50%34.19M27.25%37.29M22.08%107.52M-1.48%25.2M35.03%27.21M25.45%25.81M34.56%29.3M16.89%88.08M32.54%25.58M
Selling and administrative expenses 92.55%15.66M30.13%13.28M140.78%17.44M31.40%35.51M51.26%9.93M34.56%8.13M51.19%10.2M-5.52%7.24M9.38%27.02M-8.02%6.56M
Research and development costs 0.48%19.17M34.06%20.91M-10.01%19.85M17.95%72.02M-19.68%15.27M35.23%19.08M12.88%15.6M56.33%22.06M20.56%61.06M56.34%19.01M
Operating profit -26.77%-34.5M-31.36%-33.9M-27.25%-37.29M-22.08%-107.52M1.48%-25.2M-35.03%-27.21M-25.45%-25.81M-34.56%-29.3M-16.89%-88.08M-32.54%-25.58M
Net non-operating interest income expense -120.73%-543K-161.11%-611K-194.89%-808K68.34%-1.2M53.38%-441K75.50%-246K74.40%-234K69.89%-274K-3.91%-3.77M-2.60%-946K
Non-operating interest income 34.80%1.87M71.23%1.57M27.66%1.07M1,992.24%4.58M629.80%1.45M9,814.29%1.39M22,750.00%914K27,733.33%835K2,090.00%219K6,500.00%198K
Non-operating interest expense 47.74%2.41M89.55%2.18M68.98%1.87M44.68%5.78M64.86%1.89M60.51%1.63M25.05%1.15M21.47%1.11M9.64%3.99M23.68%1.14M
Other net income (expense) -106.50%-1.64M522.68%125.36M-345.42%-13.65M483.90%7.63M354.89%6.54M5,809.98%25.18M-10,845.65%-29.66M646.58%5.56M79.51%-1.99M74.29%-2.57M
Gain on sale of security -107.41%-1.86M167.70%20.22M-352.90%-13.76M315.87%7.07M432.02%6.33M--25.16M-9,013.43%-29.86M2,990.34%5.44M564.75%1.7M460.61%1.19M
Special income (charges) --0--105M------0--0--0--0----105.22%509K--0
-Less:Impairment of capital assets --------------0------------------0----
-Gain on sale of property,plant,equipment --0--105M------0--0--0--0------509K--0
Other non- operating income (expenses) 1,229.41%226K-28.71%144K-14.63%105K113.20%554K105.64%212K103.85%17K442.37%202K105.00%123K-1,085.21%-4.2M-3,747.57%-3.76M
Income before tax -1,509.52%-36.68M263.12%90.85M-115.47%-51.75M-7.73%-101.09M34.35%-19.1M89.45%-2.28M-162.62%-55.7M-9.45%-24.02M-5.82%-93.84M3.69%-29.09M
Income tax -42.31%15K20.00%18K375.00%19K178.57%78K135.71%33K300.00%26K275.00%15K-82.61%4K64.71%28K366.67%14K
Net income -1,492.02%-36.7M263.04%90.83M-115.51%-51.77M-7.78%-101.17M34.27%-19.13M89.32%-2.31M-162.64%-55.71M-9.36%-24.02M-5.83%-93.87M3.65%-29.1M
Net income continuous Operations -1,492.02%-36.7M263.04%90.83M-115.51%-51.77M-7.78%-101.17M34.27%-19.13M89.32%-2.31M-162.64%-55.71M-9.36%-24.02M-5.83%-93.87M3.65%-29.1M
Minority interest income
Net income attributable to the parent company -1,492.02%-36.7M263.04%90.83M-115.51%-51.77M-7.78%-101.17M34.27%-19.13M89.32%-2.31M-162.64%-55.71M-9.36%-24.02M-5.83%-93.87M3.65%-29.1M
Preferred stock dividends
Other preferred stock dividends 0-81.74%2.55M0
Net income attributable to common stockholders -1,492.02%-36.7M263.04%90.83M-115.51%-51.77M-4.93%-101.17M34.27%-19.13M89.46%-2.31M-162.64%-55.71M0.84%-24.02M6.07%-96.41M18.96%-29.1M
Basic earnings per share
Diluted earnings per share
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data